article thumbnail

NHS data sharing scheme “on hold” as millions opt out

pharmaphorum

The centralised database of medical records from 55 million people was first unveiled in May and due to come online on 1 July, but had its start date pushed back to 1 September after campaigners pushed back against the proposals. Now that’s been set back indefinitely. survey conducted in July.

article thumbnail

How using AI in clinical trials accelerates drug development

Pharmaceutical Technology

The need for new medical treatments and drugs has never been greater. But before pharmaceutical companies can go to market with a breakthrough drug, they need to ensure safety and efficacy through clinical trials. More than two-thirds of R&D companies say projects have been delayed due to missing information.

article thumbnail

Adherence to NICE criteria for initiation and continuation of treatment with a biologic in atopic dermatitis

Hospital Pharmacy Europe

A patient access scheme or commercial arrangement associated with the NICE guidance is a way for pharmaceutical companies to lower the acquisition cost to the NHS to improve its cost-effectiveness, so enabling patients to gain access to high-cost medicine treatments. The NHS price for dupilumab excluding VAT is £1,264.89 Conclusion.